461 related articles for article (PubMed ID: 16207846)
21. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
23. Modifier genes in cystic fibrosis lung disease.
Merlo CA; Boyle MP
J Lab Clin Med; 2003 Apr; 141(4):237-41. PubMed ID: 12677168
[TBL] [Abstract][Full Text] [Related]
24. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
Salvatore F; Scudiero O; Castaldo G
Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
[TBL] [Abstract][Full Text] [Related]
25. Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.
Haerynck F; Mahachie John JM; Van Steen K; Schelstraete P; Van daele S; Loeys B; Van Thielen M; De Canck I; Nuytinck L; De Baets F
Hum Immunol; 2013 Dec; 74(12):1649-55. PubMed ID: 23994582
[TBL] [Abstract][Full Text] [Related]
26. Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls.
Weiss FU; Simon P; Bogdanova N; Mayerle J; Dworniczak B; Horst J; Lerch MM
Gut; 2005 Oct; 54(10):1456-60. PubMed ID: 15987793
[TBL] [Abstract][Full Text] [Related]
27. Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: study of 19 heterozygous and 2 homozygous patients.
Casals T; Pacheco P; Barreto C; Giménez J; Ramos MD; Pereira S; Pinheiro JA; Cobos N; Curvelo A; Vázquez C; Rocha H; Séculi JL; Pérez E; Dapena J; Carrilho E; Duarte A; Palacio AM; Nunes V; Lavinha J; Estivill X
Hum Mutat; 1997; 10(5):387-92. PubMed ID: 9375855
[TBL] [Abstract][Full Text] [Related]
28. Diverse genotypical features and impacts on clinical course and severity of cystic fibrosis: early childhood experience.
Halicioglu O; Akman SA; Sutcuoglu S; Coker I
Minerva Pediatr; 2011 Jun; 63(3):169-75. PubMed ID: 21654597
[TBL] [Abstract][Full Text] [Related]
29. Finding genetic modifiers of cystic fibrosis.
Haston CK; Hudson TJ
N Engl J Med; 2005 Oct; 353(14):1509-11. PubMed ID: 16207854
[No Abstract] [Full Text] [Related]
30. Cystic fibrosis mutations with widely variable phenotype: the D1152H example.
Mussaffi H; Prais D; Mei-Zahav M; Blau H
Pediatr Pulmonol; 2006 Mar; 41(3):250-4. PubMed ID: 16429425
[TBL] [Abstract][Full Text] [Related]
31. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
[TBL] [Abstract][Full Text] [Related]
32. [Correlation between phenotype and genotype in a group of patients with cystic fibrosis].
Navarro H; Kolbach M; Repetto G; Guiraldes E; Harris P; Foradori A; Poggi H; Sánchez I
Rev Med Chil; 2002 May; 130(5):475-81. PubMed ID: 12143267
[TBL] [Abstract][Full Text] [Related]
33. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
[TBL] [Abstract][Full Text] [Related]
34. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
35. Disease modifying genes in cystic fibrosis.
Slieker MG; Sanders EA; Rijkers GT; Ruven HJ; van der Ent CK
J Cyst Fibros; 2005 Aug; 4 Suppl 2():7-13. PubMed ID: 15996905
[TBL] [Abstract][Full Text] [Related]
36. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
[TBL] [Abstract][Full Text] [Related]
37. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India.
Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS
J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958
[TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France.
Duguépéroux I; De Braekeleer M;
J Cyst Fibros; 2004 Dec; 3(4):259-63. PubMed ID: 15698945
[TBL] [Abstract][Full Text] [Related]
39. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
Burgel PR; Fajac I; Hubert D; Grenet D; Stremler N; Roussey M; Siret D; Languepin J; Mely L; Fanton A; Labbé A; Domblides P; Vic P; Dagorne M; Reynaud-Gaubert M; Counil F; Varaigne F; Bienvenu T; Bellis G; Dusser D
Clin Genet; 2010 Apr; 77(4):355-64. PubMed ID: 19843100
[TBL] [Abstract][Full Text] [Related]
40. CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity.
Blaisdell CJ; Howard TD; Stern A; Bamford P; Bleecker ER; Stine OC
BMC Med Genet; 2004 Oct; 5():26. PubMed ID: 15507145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
